General MedicationsINTRAVENOUSGeneric
REZIPRES
EPHEDRINE HYDROCHLORIDE
Standard Dose
47MG/10ML (4.7MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview REZIPRES is listed in Drugs@FDA under application 213536 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EPHEDRINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 47MG/10ML (4.7MG/ML) Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2021-06-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview REZIPRES is listed in Drugs@FDA under application 213536 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPHEDRINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 47MG/10ML (4.7MG/ML) Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2021-06-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.